Published in Immunology on December 01, 1986
Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med (1990) 5.35
Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med (1987) 5.14
Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol (2000) 4.87
Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med (1989) 3.16
Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology (1992) 3.09
Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med (1993) 2.92
Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci U S A (1992) 2.77
Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J Exp Med (2008) 2.73
Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues. J Exp Med (1988) 2.73
Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J Exp Med (1990) 2.54
Lymphoid dendritic cells. Immunology (1987) 2.08
Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology (1995) 1.86
Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology (1997) 1.76
The route of antigen entry determines the requirement for L-selectin during immune responses. J Exp Med (1996) 1.61
Suppression of immune responses by dendritic cells infected with HIV. Immunology (1989) 1.61
Phenotypic characteristics of antigen-bearing cells in the draining lymph nodes of contact sensitized mice. Immunology (1990) 1.46
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc Natl Acad Sci U S A (1999) 1.46
MHC class II expression by Langerhans' cells and lymph node dendritic cells: possible evidence for maturation of Langerhans' cells following contact sensitization. Immunology (1991) 1.42
Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice. J Virol (1998) 1.35
Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-alpha. Immunology (1994) 1.33
CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes. J Exp Med (2000) 1.33
CD45RC isoforms define two types of CD4 memory T cells, one of which depends on persisting antigen. J Exp Med (1997) 1.32
Antigen-bearing dendritic cells in the draining lymph nodes of contact sensitized mice: cluster formation with lymphocytes. Immunology (1991) 1.31
Systemic migration of dendritic cells during contact sensitization. Immunology (1990) 1.24
Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein. Am J Pathol (1996) 1.21
Lymph-borne (veiled) dendritic cells can acquire and present intestinally administered antigens. Immunology (1991) 1.17
Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice. J Exp Med (1996) 1.14
Identification of dendritic cells as a major source of interleukin-6 in draining lymph nodes following skin sensitization of mice. Immunology (1995) 1.11
The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers. Proc Natl Acad Sci U S A (1997) 1.11
The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration. Immunology (1992) 1.09
Role of tumour necrosis factor-alpha in ultraviolet B light-induced dendritic cell migration and suppression of contact hypersensitivity. Immunology (1994) 1.09
Immortalized dendritic cell line fully competent in antigen presentation initiates primary T cell responses in vivo. J Exp Med (1993) 1.05
CD8 T cells producing IL-17 and IFN-gamma initiate the innate immune response required for responses to antigen skin challenge. J Immunol (2009) 1.05
Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism. Immunology (2001) 1.03
Dendritic cells and T cells transfer sensitization for delayed-type hypersensitivity after skin painting with contact sensitizer. Immunology (1989) 0.97
Langerhans' cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens. Immunology (1997) 0.96
Antigen-specific inhibition of IL-2 and IL-3 production in contact sensitivity to TNP. Immunology (1989) 0.96
Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivo. Immunology (2009) 0.95
Regulation of epidermal Langerhans cell migration by lactoferrin. Immunology (2000) 0.94
MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses. PLoS One (2008) 0.93
Interleukin-21 stimulates antigen uptake, protease activity, survival and induction of CD4+ T cell proliferation by murine macrophages. Clin Exp Immunol (2008) 0.91
Lipopolysaccharide-induced maturation of bone marrow-derived dendritic cells is regulated by notch signaling through the up-regulation of CXCR4. J Biol Chem (2009) 0.90
The distribution and functional properties of dendritic cells in patients with seronegative arthritis. Clin Exp Immunol (1991) 0.90
Differential function of dendritic cells isolated from blood and lymph nodes. Immunology (1994) 0.88
Alterations in dendritic cell phenotype and function associated with immunoenhancing effects of a subcutaneously administered cyclophosphamide derivative. Immunology (1991) 0.88
Low-dose exposure to antigen induces sub-clinical sensitization. Clin Exp Immunol (1990) 0.88
Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells. Immunology (1996) 0.87
Constitutive and inducible expression of interleukin-6 by Langerhans cells and lymph node dendritic cells. Immunology (1996) 0.86
Is maturation required for Langerhans cell migration? J Exp Med (2002) 0.85
Antigenic competition in contact sensitivity. Evidence for changes in dendritic cell migration and antigen handling. Immunology (1990) 0.85
Progressor but not regressor skin tumours inhibit Langerhans' cell migration from epidermis to local lymph nodes. Immunology (1999) 0.85
Identification of three distinct subsets of migrating dendritic cells from oral mucosa within the regional lymph nodes. Immunology (2009) 0.81
Role of epidermal Langerhans' cells in the induction of protective immunity to Schistosoma mansoni in guinea-pigs. Immunology (1995) 0.80
In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells. Immunology (1993) 0.79
Migration of human antigen-presenting cells in a human skin graft onto nude mice model after contact sensitization. Immunology (1995) 0.78
Protein-kinase-specific inhibitors block Langerhans' cell migration by inhibiting interleukin-1alpha release. Immunology (1999) 0.77
Dendritic cell migration limits the duration of CD8+ T-cell priming to peripheral viral antigen. J Virol (2010) 0.76
Cellular and subcellular distribution of 2,4-dinitrophenyl groups in mouse epidermis and regional lymph nodes after epicutaneous application of 2,4-dinitrofluorobenzene. Arch Dermatol Res (1991) 0.75
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol (1981) 12.96
A monoclonal antibody specific for mouse dendritic cells. Proc Natl Acad Sci U S A (1982) 5.77
Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol (1976) 4.52
The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen. Cell Immunol (1985) 2.43
Direct fluorescent labeling of cells with fluorescein or rhodamine isothiocyanate. I. Technical aspects. J Immunol Methods (1980) 2.03
Veiled cells--"dendritic cells" of the peripheral lymph. Immunobiology (1984) 1.86
Induction of cell-mediated immunity in the mouse: circumstantial evidence for highly immunogenic antigen in the regional lymph nodes following skin painting with contact sensitizing agents. Isr J Med Sci (1976) 1.63
The role of dendritic cells in the initiation of immune responses to contact sensitizers. II. Studies in nude mice. Cell Immunol (1985) 1.62
A simple technique for harvesting lymphocytes cultured in Terasaki plates. J Immunol Methods (1979) 1.58
Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity. J Immunol (1984) 1.55
Distribution of immunogenic cells after painting with the contact sensitizers fluorescein isothiocyanate and oxazolone. Different sensitizers form immunogenic complexes with different cell populations. Immunology (1980) 1.53
The defect in delayed-type hypersensitivity of young adult SJL mice is due to a lack of functional antigen-presenting cells. Eur J Immunol (1985) 1.25
Coral reefs under rapid climate change and ocean acidification. Science (2007) 26.35
Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (1993) 19.80
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol (2001) 7.43
Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med (1987) 5.14
T cell genetic background determines default T helper phenotype development in vitro. J Exp Med (1995) 3.18
Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med (1989) 3.16
B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation. J Exp Med (1994) 2.85
Neoplastic change in duplications of the alimentary tract. Br J Surg (1975) 2.77
Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Immunology (1986) 2.72
In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol (1990) 2.70
Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J Immunol (1996) 2.68
Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood (1990) 2.68
Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc Natl Acad Sci U S A (1983) 2.68
Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology (1990) 2.58
Role of veiled cells in lymphocyte activation. Eur J Immunol (1982) 2.50
The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen. Cell Immunol (1985) 2.43
Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. J Gen Virol (1987) 2.38
Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut (2004) 2.29
Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol (1999) 2.01
Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol (1993) 2.00
Veiled cells--"dendritic cells" of the peripheral lymph. Immunobiology (1984) 1.86
The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut (2003) 1.84
Pathogen-induced Th1 phenotype development in CD4+ alpha beta-TCR transgenic T cells is macrophage dependent. Int Immunol (1993) 1.80
Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis (2009) 1.75
Conditions for measuring DNA synthesis in PHA stimulated human lymphocytes in 20 microliters hanging drops with various cell concentrations and periods of culture. J Immunol Methods (1980) 1.66
Migration and maturation of human colonic dendritic cells. J Immunol (2001) 1.64
The role of dendritic cells in the initiation of immune responses to contact sensitizers. II. Studies in nude mice. Cell Immunol (1985) 1.62
Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol (1994) 1.61
Suppression of immune responses by dendritic cells infected with HIV. Immunology (1989) 1.61
Exceptional lymphocyte stimulating capacity of cells from lymphoid cell lines. Nature (1969) 1.60
Distribution of immunogenic cells after painting with the contact sensitizers fluorescein isothiocyanate and oxazolone. Different sensitizers form immunogenic complexes with different cell populations. Immunology (1980) 1.53
Immunologic reactivity in rheumatoid arthritis. Response to mitogens. Arthritis Rheum (1974) 1.52
Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res Hum Retroviruses (1992) 1.45
Reduction of lymphocyte transformation by a factor produced by gastrointestinal cancer. Lancet (1973) 1.44
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
Defective low-density cells of dendritic morphology from the blood of patients with common variable hypogammaglobulinaemia: low immunoglobulin production on stimulation of normal B cells. Clin Exp Immunol (1985) 1.42
The health care needs of southeast asian refugees. Can Fam Physician (1988) 1.38
IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J Immunol (1998) 1.38
The circulating immunoglobulins involved in protective immunity to the intestinal stage of Nippostrongylus brasiliensis in the rat. Immunology (1970) 1.36
Morphology and phenotype of dendritic cells from peripheral blood and their productive and non-productive infection with human immunodeficiency virus type 1. Immunology (1991) 1.36
Veiled (dendritic) cells in synovial fluid. Lancet (1983) 1.30
Antigen-presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection. Immunology (1992) 1.30
Experience with coeliac axis compression syndrome. Br Med J (1970) 1.30
Systemic migration of dendritic cells during contact sensitization. Immunology (1990) 1.24
Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells. Immunology (1991) 1.23
Ultrastructural appearance of freeze-substituted lymphocytes frozen by interrupting rapid cooling with a period at--26 degrees C. Cryobiology (1975) 1.21
T-cell-mediated enhancement of host-versus-graft reactivity in mice fed a diet enriched in vitamin A acetate. Nature (1983) 1.20
Actin may be present on the lymphocyte surface. Proc Natl Acad Sci U S A (1978) 1.19
Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro. Eur J Immunol (1999) 1.17
Help and suppression by lymphoid cells as a function of cellular concentration. Proc Natl Acad Sci U S A (1979) 1.16
Suppression of collagen type II-induced arthritis by transfer of lymphoid cells from rats immunized with collagen. Clin Exp Immunol (1985) 1.15
Primary human T-cell responses to the major outer membrane protein of Chlamydia trachomatis. Immunology (1993) 1.13
Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin Exp Immunol (2005) 1.13
Separation of populations of human lymphocytes by freezing and thawing. Nat New Biol (1972) 1.10
Optimal recovery of lymphocytes and tissue culture cells following rapid cooling. Nature (1974) 1.10
Evidence for an excess of B→D*τ(-)ν(τ) decays. Phys Rev Lett (2012) 1.10
Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut (2005) 1.09
HIV I infection of dendritic cells. Int Rev Immunol (1990) 1.09
Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. I. Histology and weight of lymph nodes, spleen, and thymus. J Natl Cancer Inst (1971) 1.09
Observation of time-reversal violation in the B0 meson system. Phys Rev Lett (2012) 1.09
Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report. Lancet (1982) 1.09
The effect of immunity upon some enzymes of the parasitic nematode, Nippostrongylus brasiliensis. Parasitology (1971) 1.08
Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis. Clin Exp Immunol (1993) 1.08
Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect Immun (1998) 1.07
Precise measurement of the e+e- --> pi+pi-(gamma) cross section with the initial state radiation method at BABAR. Phys Rev Lett (2009) 1.07
Double-blind, controlled trial of immunosuppression in treatment of multiple sclerosis. Lancet (1980) 1.06
Retrovirally induced switch from production of IL-12 to IL-4 in dendritic cells. Eur J Immunol (1999) 1.05
Measurement of |V(cb)| and the form-factor slope in B --> Dl- nu(l) decays in events tagged by a fully reconstructed B meson. Phys Rev Lett (2010) 1.05
Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia. Leukemia (2003) 1.04
HLA-B27 subtypes in the spondarthropathies. Clin Exp Immunol (1993) 1.03
Class II histocompatibility antigens on human dendritic cells. Immunology (1987) 1.03
Changes in the populations of lymphoid cells in human peripheral blood following physical exercise. Clin Exp Immunol (1984) 1.03
Microplate culture of mouse lymph node cells. I. Quantitation of responses to allogeneic lymphocytes endotoxin and phytomitogens. J Immunol Methods (1974) 1.02
Influence of dendritic cells on tumor growth. Proc Natl Acad Sci U S A (1985) 1.02
Intestinal dendritic cells: their role in bacterial recognition, lymphocyte homing, and intestinal inflammation. Inflamm Bowel Dis (2010) 1.01
Preparation of an antiserum specific for rat reagin (rat E?). Immunology (1971) 1.01
The distribution of dendritic cells in the synovial fluids of patients with arthritis. Clin Exp Immunol (1986) 1.01
Gut mucosal response to food antigens in Crohn's disease. Aliment Pharmacol Ther (2002) 1.00
Use of a cell rupturing pump for the preparation of thymocyte subcellular fractions. J Immunol Methods (1974) 0.99
Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. 3. Plaque-forming cell response in lymph nodes and spleen. J Natl Cancer Inst (1971) 0.98
MHC class II molecules transferred between allogeneic dendritic cells stimulate primary mixed leukocyte reactions. Int Immunol (1999) 0.98
Dendritic cells and T cells transfer sensitization for delayed-type hypersensitivity after skin painting with contact sensitizer. Immunology (1989) 0.97
Enzymic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6-sialytransferase. Blood (1991) 0.96
Cellular immunity in multiple sclerosis. Br Med Bull (1977) 0.96
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96
Human retinal microglia: expression of immune markers and relationship to the glia limitans. Glia (1995) 0.94
Thymic dependency of tumor-induced immunodepression. J Natl Cancer Inst (1973) 0.94
Bioavailability of carotenoids in human subjects. Proc Nutr Soc (1999) 0.93
Cell number requirements for lymphocyte stimulation in vitro: changes during the course of multiple sclerosis and the effects of immunosuppression. Clin Exp Immunol (1981) 0.93
Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules. Immunology (1994) 0.92
Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease. Inflamm Bowel Dis (2010) 0.92
CD4 expression on dendritic cells and their infection by human immunodeficiency virus. J Gen Virol (1995) 0.92
Bone-marrow-derived dendritic cells and the pathogenesis of AIDS. AIDS (1996) 0.91